S100A8 and S100A9 have been shown to be pro-tumorigenic by inducing accumulation of MDSCs at the tumor site43,44 and enhancing angiogenesis45, on the other hand, have proven to be immune activating by enhancing NK cells activity46. This evidence concerns the gene S100A8 and neoplasm.